Plasma pharmacokinetic and metabolism of [


Journal

Nuclear medicine and biology
ISSN: 1872-9614
Titre abrégé: Nucl Med Biol
Pays: United States
ID NLM: 9304420

Informations de publication

Date de publication:
Historique:
received: 14 10 2019
revised: 08 01 2020
accepted: 12 01 2020
pubmed: 26 1 2020
medline: 14 7 2021
entrez: 26 1 2020
Statut: ppublish

Résumé

Tau deposition is one of the hallmarks of Alzheimer's disease (AD) and can be visualized and quantified using [ Female and male rats (n = 11-12) were cannulated via the femoral artery for continuous blood sampling. Blood sampling was performed at regular intervals after intravenous injection of [ Plasma pharmacokinetics and metabolism were significantly different between female and male rats. [ Our results show pronounced sex differences in blood/plasma pharmacokinetics and metabolism of [ First preclinical study in rats showing pronounced sex differences in blood/plasma pharmacokinetics and metabolism of [ Sex-specific differences might also be present in humans and thus clinical trials should have adequate sample size to account for effects in men and women separately.

Identifiants

pubmed: 31981857
pii: S0969-8051(19)30518-9
doi: 10.1016/j.nucmedbio.2020.01.001
pii:
doi:

Substances chimiques

6-((3-fluoro-2-hydroxy)propoxy)-2-(4-methylaminophenyl)quinoline 0
Aniline Compounds 0
Quinolines 0
Radioactive Tracers 0
tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-32

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Severin Mairinger (S)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria.

Thomas Filip (T)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria.

Michael Sauberer (M)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria.

Stefanie Flunkert (S)

Neuropharmacology, QPS Austria GmbH, Grambach, Austria.

Thomas Wanek (T)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria.

Johann Stanek (J)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria.

Sara Furtner (S)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria.

Birgit Hutter-Paier (B)

Neuropharmacology, QPS Austria GmbH, Grambach, Austria.

Nobuyuki Okamura (N)

Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Claudia Kuntner (C)

Preclinical Molecular Imaging, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, Austria. Electronic address: claudia.kuntner@ait.ac.at.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH